|Bid||3.91 x 1000|
|Ask||4.68 x 2000|
|Day's Range||4.15 - 4.41|
|52 Week Range||4.08 - 13.30|
|PE Ratio (TTM)||-4.49|
|Earnings Date||Oct 30, 2017 - Nov 3, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||5.44|
Categories: Yahoo FinanceGet free summary analysis Endologix, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Endologix, Inc. – LeMaitre Vascular, Inc., Boston Scientific Corporation, C. R. Bard, Inc., Baxter International Inc., Medtronic plc, Hologic, Inc., Cardiovascular Systems, Inc. and Merit Medical Systems, Inc. (LMAT-US, ... Read more (Read more...)
Endologix, Inc. , a developer and marketer of innovative treatments for aortic disorders, today announced the CE Mark approval for its Nellix® EndoVascular Aneurysm Sealing System with the refined Indications for Use .
Endologix Inc (NASDAQ:ELGX), a healthcare equipment and services company based in United States, See our latest analysis for ELGX What’s the opportunity in ELGX? The stock seems fairly valued atRead More...